FDA approves new psoriasis drug || Valeant Pharmaceuticals || Katalyst HLS

The U.S. Food and Drug Administration today approved Siliq (brodalumab) to treat adults with moderate-to-severe plaque psoriasis. Siliq is administered as an injection. http://www.fda.gov/ || www.KatalystHLS.com
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm541981.htm